group_id	acute/sustained preclinical	gnotobiotic preclinical	animal strain preclinical	animal sex preclinical	animal age value (days) preclinical	animal weight value (g) preclinical	species preclinical	disease model preclinical	prophylactic / therapeutic preclinical	ribotype preclinical	c diff strain preclinical	c diff dose value preclinical	c diff dose units preclinical	c diff dose vegetative/spores preclinical	daily dosage preclinical	total dosage preclinical	dosage value preclinical	dosage times per day preclinical	dosage duration preclinical	result preclinical	acute/sustained clinical	daily dosage clinical	total dosage clinical	dosage value clinical	dosage times per day clinical	dosage duration clinical	prophylactic / therapeutic clinical	Age Groups clinical	Phases clinical	result clinical	intervention
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	504.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26917573_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01085591	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01085591	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01983683	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01983683	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01987895	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01987895	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT02254967	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT02254967	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01597505	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01597505	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01598311	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01598311	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT02179658	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT02179658	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT02743234	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT02743234	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01222702	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01222702	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT02218372	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT02218372	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT00468728	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT00468728	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT00314951	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT00314951	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT00269399	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT00269399	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT00196794	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT00196794	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT00106509	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT00106509	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT02092935	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT02092935	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01818141	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23689716_https://ClinicalTrials.gov/show/NCT01818141	acute	axenic	pig	Unknown	5.0		pig	challenge	t	27.0	uk6	1000000	Unknown	spores	40.0	280.0	20	2	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25824219_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	c57bl/6	m	39.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23324518_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	54.0	93.0	hamster	clindamycin+challenge	t	12.0	atcc43596	3400000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29483125_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	f	42.0	100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	10.0	50.0	5	2	5.0	0.4	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	1.0	5.0	0.5	2	5.0	0.625	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/19251726_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m	42.0	99.0	hamster	clindamycin+challenge	t	12.0	atcc43596	16000000	cfu	vegetative	10.0	50.0	5	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	c57bl/6	Unknown	56.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	10	2	5.0	0.2	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	10000	cfu	Unknown	20.0	100.0	20	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	50000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	50.0	50	1	1.0	0.5	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	100.0	50	1	2.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	150.0	50	1	3.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	50.0	250.0	50	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.3333333333333333	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	200.0	20	1	10.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/23217055_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	150.0	50	1	3.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/26832756_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	vegetative	20.0	100.0	20	1	5.0	0.3684210526315789	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29109161_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	56.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	1000000	cfu	vegetative	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30482680_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6j	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	500000	Unknown	spores	50.0	250.0	50	1	5.0	0.3888888888888889	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.8823529411764706	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.0909090909090909	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.7058823529411765	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8181818181818182	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18848941_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	f	63.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	p	87.0	vpi10463	10000	cfu	Unknown	50.0	50.0	50	1	1.0	0.4166666666666667	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5416666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.6875	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24514098_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		98.0	hamster	clindamycin+challenge	t	53.0	b1	53	Unknown	spores	12.5	50.0	6.25	2	4.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/27527088_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	680	cfu	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01085591	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01983683	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01987895	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01597505	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01598311	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01222702	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00269399	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00196794	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00106509	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01085591	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01983683	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01987895	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01597505	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01598311	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01222702	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00269399	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00196794	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00106509	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	20.0	100.0	10	2	5.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	5000000	cfu	spores	100.0	300.0	50	2	3.0	0.1666666666666666	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/30736358_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		100.0	hamster	clindamycin+challenge	t	12.0	630	100	Unknown	spores	20.0	60.0	20	1	3.0	0.1	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	50.0	300.0	50	1	6.0	0.3	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/15388461_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	Unknown		113.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.3571428571428571	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.9	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.25	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.125	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	0.375	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22203600_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	f		85.0	hamster	clindamycin+challenge	t	87.0	vpi10463	10000000	cfu	spores	100.0	300.0	50	2	3.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	100.0	500.0	50	2	5.0	0.8333333333333334	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	100.0	500.0	50	2	5.0	0.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/33782498_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	428.0	va11	7500000	cfu	Unknown	20.0	100.0	20	1	5.0	0.7	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	40.0	200.0	20	2	5.0	0.55	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8939393939393939	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6440677966101694	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8538205980066446	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6179401993355482	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8490566037735849	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6226415094339622	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.8212290502793296	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.5921787709497207	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8357142857142857	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6107142857142858	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8184931506849316	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.589041095890411	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8796296296296297	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6574074074074074	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.1875	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.3125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.8636363636363636	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.5454545454545454	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7045454545454546	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	child	phase3	0.7419354838709677	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.86328125	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7792792792792793	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.8566775244299675	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	child,adult,olderadult	phase3	0.7452471482889734	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.6347826086956522	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.863013698630137	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.808	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8235294117647058	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.8059701492537313	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase3	0.7570093457943925	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.696969696969697	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	sustained	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase2	0.6086956521739131	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	0.6666666666666666	vancomycin
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.6	acute	500.0	5000.0	125.0	4	10.0	t	adult,olderadult	phase4	1.0	vancomycin
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.4	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.4	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.4	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.4	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.4	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.4	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.4	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.4	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.4	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.4	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	1.0	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	1.0	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	1.0	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	1.0	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	1.0	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	1.0	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	1.0	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	1.0	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	1.0	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	1.0	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	1.0	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	1.0	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	1.0	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	1.0	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.2	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.2	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.2	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.2	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.2	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.2	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.2	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.2	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.2	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.3	1.5	0.3	1	5.0	0.2	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	0.4	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	0.4	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	0.4	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	0.4	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	0.4	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	0.4	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	0.4	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	0.4	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	0.4	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	10.0	50.0	10	1	5.0	0.4	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	0.8	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	0.8	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	0.8	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	0.8	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	0.8	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	0.8	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	0.8	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	0.8	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	0.8	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	100.0	500.0	100	1	5.0	0.8	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.4	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.4	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.4	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.4	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.4	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.4	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.4	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.4	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.4	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	12.5	62.5	12.5	1	5.0	0.4	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.6	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.6	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.6	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.6	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.6	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.6	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.6	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.6	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.6	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	25.0	125.0	25	1	5.0	0.6	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.2	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.2	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.2	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.2	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.2	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.2	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.2	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.2	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.2	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	3.0	15.0	3	1	5.0	0.2	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.5	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.5	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.5	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.5	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.5	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.5	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.5	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.5	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.5	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	30.0	150.0	30	1	5.0	0.5	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.6	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.6	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.6	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.6	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.6	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.6	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.6	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.6	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.6	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	300.0	1500.0	300	1	5.0	0.6	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	0.4	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	0.4	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	0.4	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	0.4	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	0.4	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	0.4	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	0.4	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	0.4	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	0.4	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	goldensyrian	m	58.0	111.0	hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	50.0	250.0	50	1	5.0	0.4	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4672897196261682	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4672897196261682	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4672897196261682	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4672897196261682	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4672897196261682	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4672897196261682	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4672897196261682	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4672897196261682	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4672897196261682	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4672897196261682	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9649122807017544	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9649122807017544	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9649122807017544	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9649122807017544	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9649122807017544	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9649122807017544	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9649122807017544	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9649122807017544	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9649122807017544	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9649122807017544	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	acute	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	1.0	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4018691588785046	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4018691588785046	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4018691588785046	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4018691588785046	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4018691588785046	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4018691588785046	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4018691588785046	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4018691588785046	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4018691588785046	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	0.2	1.0	0.1	2	5.0	0.4018691588785046	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9210526315789472	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9210526315789472	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9210526315789472	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9210526315789472	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9210526315789472	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9210526315789472	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9210526315789472	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9210526315789472	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9210526315789472	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	2.0	10.0	1	2	5.0	0.9210526315789472	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8785046728971962	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8068965517241379	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01983683	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8785046728971962	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6310344827586207	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8785046728971962	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8377483443708609	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01987895	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8785046728971962	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.6556291390728477	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8785046728971962	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.9411764705882352	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8785046728971962	acute	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.9	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8785046728971962	acute	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.8421052631578947	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8785046728971962	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.7647058823529411	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8785046728971962	sustained	1000.0	10000.0	500.0	2	10.0	t	adult,olderadult	phase2	0.7	cadazolid
https://pubmed.ncbi.nlm.nih.gov/24277020_https://ClinicalTrials.gov/show/NCT01222702	sustained	Unknown	c57bl/6	f	70.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	spores	20.0	100.0	10	2	5.0	0.8785046728971962	sustained	2000.0	20000.0	1000.0	2	10.0	t	adult,olderadult	phase2	0.5555555555555556	cadazolid
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01691248	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02437591	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01691248	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02437591	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.3	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01691248	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02437591	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01691248	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02437591	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01691248	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02437591	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.04	0.2	0.04	1	5.0	0.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01691248	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02437591	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	0.2	1.0	0.2	1	5.0	0.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01691248	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02437591	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	1.0	5.0	1	1	5.0	0.3	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01691248	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02437591	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33495229_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	m	39.0		hamster	challenge+clindamycin	t	87.0	vpi10463	1000000	cfu	Unknown	5.0	25.0	5	1	5.0	0.9	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01691248	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02437591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.8	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01691248	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02437591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/22585229_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	20.0	100.0	20	1	5.0	0.2	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01691248	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02437591	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01691248	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02437591	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.1666666666666666	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01691248	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02437591	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01691248	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02437591	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	2.0	10.0	1	2	5.0	0.3	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01691248	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02437591	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01691248	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02437591	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	20.0	100.0	10	2	5.0	0.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01691248	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02437591	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01691248	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02437591	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.4	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01691248	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02437591	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01691248	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02437591	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01691248	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02437591	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01691248	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02437591	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	2.0	10.0	1	2	5.0	0.9	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01691248	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02437591	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01591863	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02179658	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02743234	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02218372	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01691248	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02437591	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00314951	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT01818141	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00097422	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT00468728	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02254967	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	5.0	25.0	2.5	2	5.0	0.9	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01691248	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02437591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.3333333333333333	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01691248	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02437591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.5	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01691248	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02437591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	3.0	15.0	3	1	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01691248	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02437591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.03	0.15	0.03	1	5.0	0.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01691248	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02437591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	30000	Unknown	spores	0.3	1.5	0.3	1	5.0	0.1666666666666666	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01691248	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02437591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01691248	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02437591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.2	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01691248	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02437591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	2.0	10.0	1	2	5.0	0.4	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01691248	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02437591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	1.0	1.0	1	1	1.0	0.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01691248	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02437591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/29439962_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	27.0	2009155	40000	Unknown	spores	3.0	15.0	3	1	5.0	0.5	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	fidaxomicin
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00182429	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	1.0	6.0	1	1	6.0	0.0	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	1.0	6.0	1	1	6.0	0.0	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	1.0	6.0	1	1	6.0	0.0	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	1.0	6.0	1	1	6.0	0.0	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	1.0	6.0	1	1	6.0	0.0	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00182429	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	0.6	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	0.6	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	0.6	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	0.6	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/33045352_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	42.0		mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	800000	cfu	spores	10.0	60.0	10	1	6.0	0.6	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00182429	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.6666666666666666	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.6666666666666666	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.6666666666666666	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.6666666666666666	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.6666666666666666	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00182429	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.6666666666666666	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.6666666666666666	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.6666666666666666	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.6666666666666666	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/26568840_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6j	f	49.0	19.0	mouse	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	t	87.0	vpi10463	200000	cfu	Unknown	50.0	500.0	50	1	10.0	0.6666666666666666	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00182429	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.5	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.5	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.5	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.5	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.5	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00182429	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.5	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.5	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.5	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.5	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/31849218_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	f	49.0		mouse	cefoperazone+clindamycin+challenge	t	87.0	vpi10463	8600000	cfu	Unknown	20.0	140.0	20	1	7.0	0.5	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00182429	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.8333333333333334	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.8333333333333334	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.8333333333333334	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.8333333333333334	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.8333333333333334	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00182429	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.8333333333333334	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.8333333333333334	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.8333333333333334	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.8333333333333334	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/23147742_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	c57bl/6	m	56.0		mouse	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	t	87.0	vpi10463	100000	Unknown	Unknown	20.0	100.0	20	1	5.0	0.8333333333333334	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00182429	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	150.0	900.0	150	1	6.0	1.0	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	150.0	900.0	150	1	6.0	1.0	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	150.0	900.0	150	1	6.0	1.0	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	150.0	900.0	150	1	6.0	1.0	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	150.0	900.0	150	1	6.0	1.0	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00182429	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	150.0	900.0	150	1	6.0	0.0	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	150.0	900.0	150	1	6.0	0.0	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	150.0	900.0	150	1	6.0	0.0	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	150.0	900.0	150	1	6.0	0.0	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/10952564_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	ttu614	100000	Unknown	Unknown	150.0	900.0	150	1	6.0	0.0	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00182429	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	210.0	1050.0	210	1	5.0	1.0	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	210.0	1050.0	210	1	5.0	1.0	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	210.0	1050.0	210	1	5.0	1.0	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	210.0	1050.0	210	1	5.0	1.0	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	210.0	1050.0	210	1	5.0	1.0	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00182429	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	210.0	1050.0	210	1	5.0	0.2	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	210.0	1050.0	210	1	5.0	0.2	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	210.0	1050.0	210	1	5.0	0.2	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	210.0	1050.0	210	1	5.0	0.2	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	210.0	1050.0	210	1	5.0	0.2	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00182429	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	300.0	1500.0	150	2	5.0	1.0	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	300.0	1500.0	150	2	5.0	1.0	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	300.0	1500.0	150	2	5.0	1.0	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	300.0	1500.0	150	2	5.0	1.0	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	300.0	1500.0	150	2	5.0	1.0	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00182429	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	300.0	1500.0	150	2	5.0	0.0	sustained	1500.0	15000.0	500.0	3	10.0	t	child,adult,olderadult	phase3	0.2	metronidazole
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	300.0	1500.0	150	2	5.0	0.0	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.725925925925926	metronidazole
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	300.0	1500.0	150	2	5.0	0.0	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.8018867924528302	metronidazole
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	300.0	1500.0	150	2	5.0	0.0	acute	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7132867132867133	metronidazole
https://pubmed.ncbi.nlm.nih.gov/22869573_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	goldensyrian	Unknown		90.0	hamster	clindamycin+challenge	t	12.0	atcc43596	50000000	cfu	Unknown	300.0	1500.0	150	2	5.0	0.0	sustained	1500.0	15000.0	375.0	4	10.0	t	adult,olderadult	phase3	0.7289719626168224	metronidazole
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.9696969696969696	acute	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.9242424242424242	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.9696969696969696	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8656716417910447	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.9696969696969696	sustained	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.7213114754098361	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.9696969696969696	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8275862068965517	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.9696969696969696	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.7896551724137931	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.9696969696969696	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.603448275862069	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.9696969696969696	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8315789473684211	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.9696969696969696	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.631578947368421	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.9242424242424242	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8656716417910447	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.7213114754098361	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8275862068965517	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.7896551724137931	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.603448275862069	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8315789473684211	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.631578947368421	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.9242424242424242	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8656716417910447	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.7213114754098361	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8275862068965517	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.7896551724137931	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.603448275862069	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8315789473684211	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.631578947368421	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.7575757575757576	acute	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.9242424242424242	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.7575757575757576	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8656716417910447	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.7575757575757576	sustained	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.7213114754098361	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.7575757575757576	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8275862068965517	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.7575757575757576	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.7896551724137931	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.7575757575757576	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.603448275862069	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.7575757575757576	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8315789473684211	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	20.0	100.0	10	2	5.0	0.7575757575757576	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.631578947368421	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5	acute	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.9242424242424242	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8656716417910447	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5	sustained	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.7213114754098361	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8275862068965517	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.7896551724137931	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.603448275862069	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8315789473684211	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	4.0	20.0	2	2	5.0	0.5	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.631578947368421	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.8125	acute	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.9242424242424242	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.8125	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8656716417910447	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.8125	sustained	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.7213114754098361	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.8125	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8275862068965517	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.8125	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.7896551724137931	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.8125	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.603448275862069	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.8125	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8315789473684211	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/22802252_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	50.0	250.0	25	2	5.0	0.8125	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.631578947368421	cb-183,315
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.9242424242424242	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8656716417910447	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.7213114754098361	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01085591	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8275862068965517	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.7896551724137931	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01597505	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.603448275862069	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8315789473684211	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01598311	acute	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.631578947368421	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.9242424242424242	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8656716417910447	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	250.0	2500.0	125.0	2	10.0	t	adult,olderadult	phase2	0.7213114754098361	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01085591	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase2	0.8275862068965517	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.7896551724137931	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01597505	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.603448275862069	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	acute	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.8315789473684211	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25993059_https://ClinicalTrials.gov/show/NCT01598311	sustained	Unknown	goldensyrian	m			hamster	clindamycin+challenge	t	12.0	atcc43596	20	Unknown	spores	0.5	2.5	0.5	1	5.0	1.0	sustained	500.0	5000.0	250.0	2	10.0	t	adult,olderadult	phase3	0.631578947368421	surotomycin
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	25.0	125.0	12.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	25.0	125.0	12.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	25.0	125.0	12.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	25.0	125.0	12.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	25.0	125.0	12.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	25.0	125.0	12.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.8	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.8	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	12.0	630	225	Unknown	spores	50.0	250.0	25	2	5.0	0.8	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	25.0	125.0	12.5	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	25.0	125.0	12.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	25.0	125.0	12.5	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	25.0	125.0	12.5	2	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	25.0	125.0	12.5	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	25.0	125.0	12.5	2	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	acute	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02092935	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25652749_https://ClinicalTrials.gov/show/NCT02784002	sustained	spf	goldensyrian	Unknown			hamster	clindamycin+challenge	t	27.0	bi1	225	Unknown	spores	50.0	250.0	25	2	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	10.0	50.0	10	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	10.0	50.0	10	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	10.0	50.0	10	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	10.0	50.0	10	1	5.0	0.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	10.0	50.0	10	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	10.0	50.0	10	1	5.0	0.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	0.55	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	0.55	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	20.0	100.0	20	1	5.0	0.55	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	27.0	va5	894206	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	10.0	50.0	10	1	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	10.0	50.0	10	1	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	10.0	50.0	10	1	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.95	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.95	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.95	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	50.0	250.0	50	1	5.0	0.95	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	50.0	250.0	50	1	5.0	0.95	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	50.0	250.0	50	1	5.0	0.95	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	10.0	50.0	10	1	5.0	0.8	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	10.0	50.0	10	1	5.0	0.8	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	10.0	50.0	10	1	5.0	0.8	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.9	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	20.0	100.0	20	1	5.0	0.9	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	50.0	250.0	50	1	5.0	0.95	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.7777777777777778	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02092935	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	50.0	250.0	50	1	5.0	0.95	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.8571428571428571	smt19969
https://pubmed.ncbi.nlm.nih.gov/25022586_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m		100.0	hamster	challenge+clindamycin	t	428.0	va11	752846	cfu	Unknown	50.0	250.0	50	1	5.0	0.95	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.5	smt19969
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01670149	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	100.0	500.0	100	1	5.0	0.8	sustained	1200.0	25200.0	400.0	3	14.0	p	adult,olderadult	phase4	0.8405797101449275	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	100.0	500.0	100	1	5.0	0.8	acute	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.5726495726495726	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	100.0	500.0	100	1	5.0	0.8	sustained	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.9104477611940298	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01670149	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	100.0	500.0	100	1	5.0	0.9	sustained	1200.0	25200.0	400.0	3	14.0	p	adult,olderadult	phase4	0.8405797101449275	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	100.0	500.0	100	1	5.0	0.9	acute	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.5726495726495726	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	100.0	500.0	100	1	5.0	0.9	sustained	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.9104477611940298	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01670149	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	25.0	125.0	25	1	5.0	0.6	sustained	1200.0	25200.0	400.0	3	14.0	p	adult,olderadult	phase4	0.8405797101449275	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	25.0	125.0	25	1	5.0	0.6	acute	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.5726495726495726	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	25.0	125.0	25	1	5.0	0.6	sustained	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.9104477611940298	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01670149	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	25.0	125.0	25	1	5.0	0.45	sustained	1200.0	25200.0	400.0	3	14.0	p	adult,olderadult	phase4	0.8405797101449275	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	25.0	125.0	25	1	5.0	0.45	acute	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.5726495726495726	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	25.0	125.0	25	1	5.0	0.45	sustained	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.9104477611940298	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01670149	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	1200.0	25200.0	400.0	3	14.0	p	adult,olderadult	phase4	0.8405797101449275	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	acute	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.5726495726495726	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	p	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.7	sustained	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.9104477611940298	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01670149	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.65	sustained	1200.0	25200.0	400.0	3	14.0	p	adult,olderadult	phase4	0.8405797101449275	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.65	acute	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.5726495726495726	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	acute	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	0.65	sustained	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.9104477611940298	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01670149	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	100.0	500.0	100	1	5.0	1.0	sustained	1200.0	25200.0	400.0	3	14.0	p	adult,olderadult	phase4	0.8405797101449275	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	100.0	500.0	100	1	5.0	1.0	acute	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.5726495726495726	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	100.0	500.0	100	1	5.0	1.0	sustained	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.9104477611940298	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01670149	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	25.0	125.0	25	1	5.0	1.0	sustained	1200.0	25200.0	400.0	3	14.0	p	adult,olderadult	phase4	0.8405797101449275	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	25.0	125.0	25	1	5.0	1.0	acute	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.5726495726495726	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	25.0	125.0	25	1	5.0	1.0	sustained	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.9104477611940298	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT01670149	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	1200.0	25200.0	400.0	3	14.0	p	adult,olderadult	phase4	0.8405797101449275	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	acute	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.5726495726495726	rifaximin
https://pubmed.ncbi.nlm.nih.gov/18195066_https://ClinicalTrials.gov/show/NCT00269399	sustained	Unknown	goldensyrian	Unknown			hamster	clindamycin+challenge	t	87.0	vpi10463	100000	cfu	Unknown	50.0	250.0	50	1	5.0	1.0	sustained	1200.0	12000.0	400.0	3	10.0	t	adult,olderadult	phase3	0.9104477611940298	rifaximin
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01691248	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02437591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01691248	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02437591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01691248	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02437591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01691248	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02437591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02784002	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01691248	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02437591	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	acute	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01691248	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02437591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	0.2	1.0	0.2	1	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01691248	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02437591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	0.6	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01691248	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02437591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	1.0	5.0	1	1	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01691248	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02437591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	Unknown	2926	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.8947368421052632	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01591863	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult	phase2	0.6578947368421053	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.8365384615384616	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02179658	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.6730769230769231	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.3333333333333333	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02743234	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase3	0.5416666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02784002	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.4615384615384615	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.7755102040816326	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02218372	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child	phase3	0.9342105263157896	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01691248	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	200.0	16000.0	200.0	1	40.0	p	adult,olderadult	phase3	0.7109634551495017	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02437591	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8788927335640139	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00314951	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8392156862745098	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.9166666666666666	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT01818141	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase4	0.5714285714285714	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.7142857142857143	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	0.8	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9375	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	100.0	1000.0	50.0	2	10.0	t	adult,olderadult	phase2	0.9	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	200.0	2000.0	100.0	2	10.0	t	adult,olderadult	phase2	1.0	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00097422	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	adult,olderadult	phase2	0.9333333333333332	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8735177865612648	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT00468728	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	4000.0	200.0	2	10.0	t	child,adult,olderadult	phase3	0.8738738738738738	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	acute	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7796610169491526	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/1929250_https://ClinicalTrials.gov/show/NCT02254967	sustained	Unknown	goldensyrian	m		90.0	hamster	clindamycin+challenge	t	1.0	atcc9689	1000000	Unknown	Unknown	5.0	25.0	5	1	5.0	1.0	sustained	400.0	5600.0	200.0	2	5.0	t	adult,olderadult	phase4	0.7005649717514124	tiacumicinsb
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	1.0	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.417910447761194	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	1.0	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9428571428571428	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	1.0	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.462406015037594	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	1.0	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9658119658119658	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	0.7	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.417910447761194	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	0.7	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9428571428571428	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	0.7	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.462406015037594	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	0.7	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9658119658119658	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1500.0	10500.0	1500	1	7.0	0.7	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.417910447761194	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1500.0	10500.0	1500	1	7.0	0.7	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9428571428571428	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1500.0	10500.0	1500	1	7.0	0.7	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.462406015037594	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1500.0	10500.0	1500	1	7.0	0.7	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9658119658119658	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.8	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.417910447761194	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.8	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9428571428571428	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.8	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.462406015037594	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.8	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9658119658119658	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.9	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.417910447761194	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.9	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9428571428571428	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.9	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.462406015037594	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	acute	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.9	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9658119658119658	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	0.9	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.417910447761194	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	0.9	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9428571428571428	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	0.9	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.462406015037594	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	0.9	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9658119658119658	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	0.7	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.417910447761194	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	0.7	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9428571428571428	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	0.7	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.462406015037594	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1000.0	7000.0	1000	1	7.0	0.7	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9658119658119658	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1500.0	10500.0	1500	1	7.0	0.7	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.417910447761194	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1500.0	10500.0	1500	1	7.0	0.7	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9428571428571428	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1500.0	10500.0	1500	1	7.0	0.7	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.462406015037594	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	1500.0	10500.0	1500	1	7.0	0.7	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9658119658119658	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.7	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.417910447761194	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.7	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9428571428571428	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.7	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.462406015037594	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	p	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.7	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9658119658119658	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.9	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.417910447761194	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00196794	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.9	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9428571428571428	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.9	acute	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.462406015037594	gt160-246
https://pubmed.ncbi.nlm.nih.gov/11451694_https://ClinicalTrials.gov/show/NCT00106509	sustained	Unknown	Unknown	Unknown			hamster	challenge+clindamycin	t	Unknown	huc2-4	1000000	cfu	Unknown	500.0	3500.0	500	1	7.0	0.9	sustained	9000.0	135000.0	3000.0	3	14.0	t	adult,olderadult	phase3	0.9658119658119658	gt160-246
